Mar 20, 2019 - Emergent (EBS) kicks off a late-stage study on its investigational anthrax vaccine AV7909.
Mar 18, 2019 - Regeneron (REGN) and partner Sanofi receives approval in Europe for the label expansion of Praluent to reduce cardiovascular (CV) risk in adults with established atherosclerotic CV disease.
Mar 13, 2019 - Key highlights of the past week are regulatory and pipeline developments.
Mar 13, 2019 - Let's see if Sanofi (SNY) stock is a good choice for value-oriented investors right now from multiple angles.
Mar 12, 2019 - The FDA approves a label expansion of Regeneron's (REGN) asthma drug, Dupixent for moderate-to-severe atopic dermatitis in adolescents.
Mar 11, 2019 - Sanofi (SNY) and partner Regeneron's (REGN) Dupixent gets FDA's priority review status for inadequately controlled severe chronic rhinosinusitis with nasal polyps.
Mar 07, 2019 -
After 13 years of unpredictable sportswriters and assorted Gasbags delivering the word and their insights on the fly every afternoon at 5 p.m., SportsNet New York is cancelling "Daily News Live" and replacing it with "The Thread" a fast-paced show covering the hottest sports news of the day.
Mar 06, 2019 - The FDA accepts Roche's (RHHBY) sNDA for Xofluza to treat influenza in people at high risk of complications.
Mar 06, 2019 - Top Stock Reports for Salesforce, Booking Holdings & VMware
Mar 06, 2019 - Pharmaceutical companies are suddenly eager to lower drug prices.